Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $21,510 | 24 | 99.8% |
| Food and Beverage | $34.14 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $21,510 | 24 | $0 (2024) |
| Genentech USA, Inc. | $19.13 | 1 | $0 (2020) |
| Advanced Respiratory, Inc | $15.01 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $750.00 | 1 | Merck Sharp & Dohme LLC ($750.00) |
| 2023 | $3,250 | 4 | Merck Sharp & Dohme LLC ($3,250) |
| 2022 | $3,000 | 3 | Merck Sharp & Dohme LLC ($3,000) |
| 2021 | $3,250 | 4 | Merck Sharp & Dohme Corporation ($3,250) |
| 2020 | $3,069 | 4 | Merck Sharp & Dohme Corporation ($3,050) |
| 2019 | $2,822 | 3 | Merck Sharp & Dohme Corporation ($2,822) |
| 2018 | $2,694 | 3 | Merck Sharp & Dohme Corporation ($2,694) |
| 2017 | $2,709 | 4 | Merck Sharp & Dohme Corporation ($2,694) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/26/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| 10/30/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| 05/03/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $200.00 | General |
| 03/22/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| 03/06/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $250.00 | General |
| 11/21/2022 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| 04/20/2022 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $200.00 | General |
| 03/16/2022 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| 12/03/2021 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $250.00 | General |
| 09/15/2021 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| 04/26/2021 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $200.00 | General |
| 03/19/2021 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| 09/25/2020 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| 06/08/2020 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $250.00 | General |
| 03/16/2020 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| 02/13/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Virology & Specialty Care | ||||||
| 10/02/2019 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $150.00 | General |
| 09/27/2019 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| 04/03/2019 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $1,272.00 | General |
| 09/20/2018 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $150.00 | General |
| 09/17/2018 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $1,272.00 | General |
| 04/02/2018 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $1,272.00 | General |
| 10/06/2017 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $150.00 | General |
| 09/20/2017 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $1,272.00 | General |
| 05/25/2017 | Advanced Respiratory, Inc | The Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Airway Clearance Device | ||||||
About Dr. Michael Cellucci, MD
Dr. Michael Cellucci, MD is a Pediatrics healthcare provider based in Wilmington, Delaware. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/21/2007. The National Provider Identifier (NPI) number assigned to this provider is 1477698892.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Cellucci, MD has received a total of $21,544 in payments from pharmaceutical and medical device companies, with $750.00 received in 2024. These payments were reported across 26 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($21,510).
Practice Information
- Specialty Pediatrics
- Other Specialties Hospitalist, Pediatrics
- Location Wilmington, DE
- Active Since 02/21/2007
- Last Updated 12/27/2011
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1477698892
Products in Payments
- Xofluza (Drug) $19.13
- The Vest System Model 105 Home Care (Device) $15.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Wilmington
Harry Chugani, Md, MD
Pediatrics — Payments: $73,932
E Kolb, Md, MD
Pediatrics — Payments: $54,692
Dr. Kateryna Kotlyarevska, Md, MD
Pediatrics — Payments: $35,871
Dr. Deborah Consolini, Md, MD
Pediatrics — Payments: $35,032
Dr. J. Malatack, M.d, M.D
Pediatrics — Payments: $25,720
Dr. Catherine Soprano, Md, MD
Pediatrics — Payments: $19,640